BioSpace News Archive

Sio Gene Therapies Inc., a clinical-stage company focused on developing gene therapies to radically improve the lives of patients with neurodegenerative diseases, announced that the company will present at the 10th Annual SVB Leerink Global Healthcare Conference taking place February 22-26, 2021.

BrainsWay Ltd., a global leader in the advanced noninvasive treatment of brain disorders, announced certain preliminary unaudited Fourth Quarter Financial Results.

AzurRx BioPharma, Inc., a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal diseases, announced that James Sapirstein, Chief Executive Officer, will present at The Microcap Rodeo Winter Wonderland Conference taking place virtually from February 16-19, 2021.

Axsome Therapeutics, Inc., a biopharmaceutical company developing novel therapies for the management of central nervous system disorders, announced that it will report its financial results for fiscal year 2020 on Monday, March 1, 2021 before the opening of the U.S. financial markets.

BetterLife invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference

Michael J. Parini joins from Vertex as President and Chief Operating Officer complementing recent General Counsel and Investor Relations appointments

Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at Citi’s 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference on Thursday, February 25, 2021 at 9:50 a.m. EST.

GW Pharmaceuticals plc, a world leader in the science, development, and commercialization of cannabinoid prescription medicines, announced financial results and operating progress for the fourth quarter and full-year ended December 31, 2020.

Signature Biologics, LLC. announced that the U.S. Food and Drug Administration has approved an IND Application to proceed with the study of Signature Cord Prime™ in patients with symptomatic osteoarthritis of the knee with our Principal Investigator.

Envista Holdings Corporation announced a four-year contract extension with Heartland Dental, the U.S.'s largest dental support organization.